Jaffe K, Richardson L "I thought it was for guys that did needles": Medication perceptions and lay expertise among medical research participants J Subst Use Addict Treat, 2023. PubMed


Socías ME, Scheuermeyer FX, Cui Z, Mok WY, Crabtree A, Fairbairn N, Nolan S, Slaunwhite A, Ti L Using a cascade of care framework to identify gaps in access to medications for alcohol use disorder in British Columbia, Canada Addiction, 2023. PubMed


Reddon H, Barker B, Bartlett S, Citlali Márquez A, Sekirov I, Jassem A, Morshed M, Clemens A, Beck McGreevy P, Hayashi K, DeBeck K, Krajden M, Milloy MJ, Socías ME Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, Canada Sci Rep, 2023. PubMed


Elefante RJO, Nolan S, Bach PJ Vigilance needed with methamphetamine-associated psychosis CMAJ, 2023. PubMed


McCracken RK, Narayan S, Maclure M, Cooper I, Cui Z, Cullen W, Dormuth C, Hamilton MA, Nolan S, Singer J, Socías ME, Wong S, Klimas J Evaluation of audit and feedback to family physicians on prescribing of opioid analgesics to opioid-naïve patients: a pragmatic randomized delay trial Contemp Clin Trials, 2023. PubMed


Karamouzian M, Rafat B, Kolla G, Urbanoski K, Atkinson K, Bardwell G, Bonn M, Touesnard N, Henderson N, Bowles J, Boyd J, Brunelle C, Eeuwes J, Fikowski J, Gomes T, Guta A, Hyshka E, Ivsins A, Kennedy MC, Laurence G, Martignetti L, Nafeh F, Salters K, Tu D, Strike C, Pauly B, Werb D Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: a qualitative analysis Int J Drug Policy, 2023. PubMed


Duncan K, Scheuermeyer F, Lane D, Ahamad K, Moe J, Dong K, Nolan S, Buxton J, Miles I, Johnson C, Christenson J, Whyte M, Daoust R, Garrod E, Badke K, Kestler A Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packs CJEM, 2023. PubMed


Small W, O'Callaghan S Commentary on Brothers et al.: The role of safer environment interventions in addressing injecting-related bacterial and fungal infections Addiction, 2023. PubMed


Bahji A, Socías ME, Bach P, Milloy MJ Implications of cannabis legalization on substance-related benefits and harms for people who use opioids: a Canadian perspective Cannabis Cannabinoid Res, 2023. PubMed


Fehr F, Lo LA, Nelson C, Nanson K, Diehl L, Nielson K, Reddon H, Walsh Z Stigma-related barriers to medical cannabis as harm reduction for substance use disorder: obstacles and opportunities for improvement Int J Ment Health Nurs, 2023. PubMed


BC Centre on Substance Use

400-1045 Howe St, Vancouver, BC V6Z 2A9


E: [email protected] | T: (778) 945-7616 | F: (604) 428-5183

24/7 Addiction Clinician Support Line: (778) 945-7619

Online Addiction Medicine Diploma: [email protected].


website logos footer

Copyright © 2023, BC Centre on Substance Use